Handelsbanken Fonder’s Medifast MED Stock Holding History

Handelsbanken Fonder’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,200	Closed	-$228K	–	1606
2023 Q1	$228K	Hold	2,200	–	–	﹤0.01%	1413
2022 Q4	$254K	Hold	2,200	–	–	﹤0.01%	1335
2022 Q3	$238K	Hold	2,200	–	–	﹤0.01%	1370
2022 Q2	$397K	Hold	2,200	–	–	﹤0.01%	1160
2022 Q1	$376K	Sell	2,200 -800	-27%	-$151K	﹤0.01%	1390
2021 Q4	$628K	Hold	3,000	–	–	﹤0.01%	1195
2021 Q3	$578K	Hold	3,000	–	–	﹤0.01%	1267
2021 Q2	$849K	Buy	3,000 +1,200	+67%	+$325K	﹤0.01%	1015
2021 Q1	$381K	Hold	1,800	–	–	﹤0.01%	1334
2020 Q4	$353K	Hold	1,800	–	–	﹤0.01%	1337
2020 Q3	$296K	Hold	1,800	–	–	﹤0.01%	1251
2020 Q2	$250K	Buy	+1,800	New	+$165K	﹤0.01%	1300

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Handelsbanken Fonder's MED Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Medifast (MED) in Q2 2023, closing a stake of 2,200 shares — an estimated $228K sold.

Handelsbanken Fonder first reported a position in MED in Q2 2020 and held it in 12 quarters. The position peaked at $849K in Q2 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Handelsbanken Fonder reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Handelsbanken Fonder sold 2,200 Medifast shares in Q2 2023, an estimated $228K.
Handelsbanken Fonder first reported a position in Medifast in Q2 2020 and held it in 12 quarters.
Handelsbanken Fonder's Medifast position peaked at $849K in Q2 2021.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.